Lung Cancers Completed Phase 2 Trials for Paclitaxel (DB01229)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00563784TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT00495170Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT00287989Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung CancerTreatment
NCT00527735Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)Treatment
NCT00661193S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00807573Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentTreatment
NCT00453167Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerTreatment
NCT00276588Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerTreatment
NCT00117442A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole BloodTreatment
NCT00193310Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung CancerTreatment
NCT00094861Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT00081302Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung CancerTreatment
NCT00085501S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00062062Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung CancerTreatment
NCT00062010Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerTreatment
NCT00062179Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerTreatment
NCT00025389Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerTreatment
NCT00033553Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung CancerTreatment
NCT00034346ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)Treatment
NCT00033696Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00021333Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerTreatment
NCT00005849Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerTreatment
NCT00005646Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment
NCT00006378Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTreatment
NCT00006004Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung CancerTreatment
NCT00005059Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung CancerTreatment
NCT00004924Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung CancerTreatment
NCT00004055Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerTreatment
NCT00004126Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung CancerTreatment
NCT00004137S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerTreatment
NCT00003881Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerTreatment
NCT00003812Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00003943Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.Treatment
NCT00003089Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerTreatment
NCT00003072Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerSupportive Care
NCT00004202Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung CancerTreatment
NCT00002972Paclitaxel in Treating Patients With Lung CancerTreatment
NCT00003281Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung CancerTreatment
NCT00003111Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerTreatment
NCT00003158S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung CancerTreatment
NCT00002969S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00003587S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerTreatment
NCT00226590Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLCTreatment
NCT01057342Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment